Euphyllinum, tablets of 150 mg No. 30

General characteristics. Structure:

Active ingredient an Euphyllinum (Aminophyllinum) - 150 mg; excipients (calcium stearate, potato starch).
Description: tablets of color, white or white with a yellowish shade, ploskotsilindrichesky with a facet.

Indications to use:

Bronkhoobstruktivny syndrome of any genesis: bronchial asthma (choice drug at patients with asthma of physical tension and as an additional tool at other forms), HOBL (emphysema of lungs, chronic obstructive bronchitis), hypertensia in a "small" circle of blood circulation, "pulmonary" heart, night an apnoea.

Route of administration and doses:

Inside, adults should appoint 150 mg to reception 1-3 times a day after food. Children inside should appoint at the rate of 7-10 mg/kg a day in 4 receptions. Duration of a course of treatment – from several days to several months, depending on the course of a disease and portability of drug. The highest doses of an Euphyllinum for adults inside: one-time-0,5, daily-1,5 the Highest doses for children inside: one-time-7 mg/kg, daily-15 mg/kg.

Features of use:

To be careful at the use of large numbers of kofeinsoderzhashchy products or drinks during treatment.

Side effects:

From a nervous system: dizziness, headache, sleeplessness, excitement, uneasiness, irritability, tremor.
From cardiovascular system: heartbeat, tachycardia (including at a fruit at reception of the pregnant woman in the III trimester), arrhythmias, a cardialgia, decrease in the ABP, increase in frequency of attacks of stenocardia.
From the alimentary system: a gastralgia, nausea, vomiting, a gastroesophageal reflux, heartburn, an aggravation of a peptic ulcer, diarrhea, at long reception – a loss of appetite.
Allergic reactions: skin rash, skin itch, fever.
Others: a stethalgia, a tachypnea, feeling of inflows to the person, an albuminuria, a hamaturia, a hypoglycemia, strengthening of a diuresis, the increased sweating. Side effects decrease at a drug dose decline.

Contraindications:

Hypersensitivity (including to other derivatives of xanthine: caffeine, пентоксифиллин, theobromine), epilepsy, a peptic ulcer of a stomach and a 12-perstny gut (in an aggravation stage – for peroral forms, especially tablets of not prolonged action), gastritis with a hyperoxemia, heavy arterial hyper - or hypotension, heavy tachyarrhythmias, a hemorrhagic stroke, an eye retinal apoplexy, children's age (up to 3 years).

Overdose:

Symptoms: a loss of appetite, a gastralgia, diarrhea, nausea, vomiting (including with blood), gastrointestinal bleeding, a tachypnea, a dermahemia of the person, tachycardia, ventricular arrhythmias, sleeplessness, motive excitement, uneasiness, a photophobia, a tremor, spasms. At a serious poisoning epileptoidny attacks (especially at children without emergence of any harbingers), a hypoxia, a metabolic acidosis, a hyperglycemia, a hypopotassemia, decrease in the ABP, a necrosis of skeletal muscles, confusion of consciousness, a renal failure with a myoglobinuria can develop. Treatment: drug withdrawal, a gastric lavage, purpose of absorbent carbon, HP laxatives, an enteroclysis a combination of polyethyleneglycol and electrolytes, an artificial diuresis, hemosorption, a plazmosorbtion, a hemodialysis (efficiency is not high, peritoneal dialysis is not effective), symptomatic therapy (including Metoclopramidum and ондансетрон – at vomiting). When developing spasms to maintain passability of respiratory tracts and to carry out an oxygenotherapy. For stopping of an attack – intravenously diazepam of 0,1-0,3 mg/kg (but no more than 10 mg). At severe nausea and vomiting – Metoclopramidum or ондансетрон (intravenously).

With CARE appoint along with anticoagulants.

Storage conditions:

Period of validity of 5 years. Not to use after expiry date. List B. In dry, protected from light and the place, unavailable to children.

Issue conditions:

According to the recipe

Packaging:

Tablets: on 150 mg.
On 10 tablets in a blister strip packaging.
On 30 tablets in banks from glass melt with a triangular nimbus like BDS, or in banks of light-protective glass with a screw mouth like BVS, or in bank polymeric the BP type.
3 blister strip packagings or to one bank together with the instruction on a medical use in a pack cardboard.